Anaxiom Corporation

Anaxiom Corporation is a medical technology company focused on developing minimally invasive approaches to obesity treatment. Its featured technology, AVOS™, is an investigational device designed to modulate blood flow through the celiac artery using controlled endovascular therapy. The company describes this approach as a way to replicate certain natural conditions associated with weight loss, with the aim of supporting weight management without surgery.

Anaxiom highlights early study findings and physician feedback about the procedure’s potential. A cardiologist cited encouraging initial evidence, while an interventional cardiologist described the procedure as straightforward and compatible with standard endovascular workflows. These comments reflect early observations, not established clinical outcomes.

The company’s website provides information about its technology, news, leadership, advisors, and board of directors, along with contact details for its Laguna Hills, California office. AVOS is investigational and is not available for commercial sale in the United States. Anaxiom’s work centers on exploring whether a catheter-based approach may offer physicians another potential tool in obesity management.